FP7 is the European Community Framework Programme for Research, Technological Development and Demonstration. FP7 will be fully operational as of 1 January 2007 and will expire in 2013. It is designed to build on the achievements of its predecessor towards the creation of the European Research Area, and carry it further towards the development of the knowledge economy and society in Europe. Please find below a selection of FP7 research projects on gene therapy.

• AAVEYE: Gene therapy for inherited severe photoreceptor diseases
• AIPGENE: Augmenting PBGD expression in the liver as a Novel Gene therapy for Acute Intermittent Porphyria
• BRAINCAV: Nonhuman adenovirus vectors for gene transfer to the brain
• CGT HEMOPHILIA A: Cell and gene therapy based strategies to correct the bleeding phenotype in Hemophilia A
• EYESEE: Development of new gene therapy approaches for the treatment of ocular neovascularization
• GENEGRAFT: Phase I/II ex vivo gene therapy clinical trial for recessive dystrophic epidermolysis bullosa using skin equivalent grafts genetically corrected with a COL7A1-encoding SIN retroviral vector
• GENETHESIS: Gene Therapy: Modeling Synthetic DNA Delivery Systems
• IRLVGTMND: Improved retrograde lentiviral vectors for gene therapy in motor neuron diseases
• LGMD2A: Development of a strategy to treat limb-girdle muscular dystrophy (LGMD2A) using combined cell and gene therapy strategies
• NEUGENE: Advanced gene therapy tools for treatment of CNS-specific disorders
• ORAL-GT-VECTOR: Development of a Novel Vector for Cancer Gene Therapy for Clinical Application
• PERSIST: Persisting transgenesis Research area: HEALTH-2007-1.4-4 Development of emerging gene therapy tools and technologies for clinical application
• REGENERATIVETHERAPY: Cell and gene therapy approaches for inherited diseases with unsatisfying or no therapeutic option
• TARGETINGGENETHERAPY: Towards Safe and Effective Hematopoietic Stem Cell Gene Therapy: Targeting Integration to Genomic Safe Harbors and Exploiting Endogenous microRNA to Regulate Transgene Expression
• TREATPD: Cell and gene therapy based approaches for treatment of Parkinson's disease: From models to clinics
• VLPSIRNA: Virus-like particles: the next step in gene therapy